Investigation of physico-chemical properties of metal complexes used in medical diagnosis and therapy by Vágner, Adrienn
  
Proposition of  Ph.D. thesis 
 
 
Investigation of physico-chemical properties of metal 
complexes used in medical diagnosis and therapy 
 
 
Adrienn Vágner  
Supervisor: Dr. Zsolt Baranyai 
 
 
 
University of Debrecen 
Ph.D. program in Chemistry 
Debrecen, 2017.
  
I. INTRODUCTION AND THE AIM OF THE WORK 
The polyaminopolycarboxilate complexes of lanthanides(III) have been used in 
different area of the medicinal diagnosis and teraphy from the 1980’s. For the 
effective applications it is nessesary to know their phisico-chemical properties. 
The biological and clinical applications are based on the special magnetic and 
optical properties of the lanthanide ions (Ln3+). The Gd3+-ion with its 
paramagnetical portperties is used in the Magnetic Resonance Imaging to increase 
the sharpness of the image. Some lanthanide(III) ions (eg. Eu3+, Sm3+, Tb3+, Nd3+, 
Er3+ és Yb3+) are used in optical imaging due to their luminescence properties. 
The 90Y 177Lu, 153Sm and 166Ho isotopes are used in the treatment of cancerous 
diseases and in the case of bone metastases for pain relief. 
Ln3+ ions are toxic and hydrolyse at physiological pH, therefore their in vivo 
application is only possible in front of stable complexes. Ln3+ ions form 
complexes of high stability with aminopolycarboxylate ligands, among which the 
parent compounds are the open-chain DTPA and the macrocyclic DOTA, 
containing 8 donor atoms. From the 1990s, several derivatives of DTPA and 
DOTA were also synthetized and their the Ln(III) complexes are commonly used 
in clinical practice (Figure 1). 
Nowadays, in addition to the lanthanides, many other 3+ charged metal ions have 
started to be used in Nuclear Medicine (eg. Sc3+, Y3+, which are also rare earth 
elements, furthermore Ga3+ and In3+). These metal ions are generally also used in 
the form of aminopolycarboxylate complexes, but the development of optimal 
ligands for the complexation of a given metal ion are still intensively investigated. 
Over the past few years the study of the equilibrium and kinetic properties of 
different metal complexes have become particularly important by recognizing the 
in vivo dissociation of the Gd(III) complexes and the discovery of a new disease, 
called Nefrogenic Systemic Fibrosis (NSF). The exact mechanism of NSF has not 
known yet, but it was assumed to be associated with the in vivo dissociation of 
GdIII complexes and the toxic effect of the released Gd3+ ions. Therefore, 
nowadays there are intensive research as in progress to determine the quantity and 
speciation of Gd3+ ions released and to explore the equilibrium and kinetic 
behavior of various Gd3+ based MRI contrast agents in vitro but close to 
physiological conditions. 
My work is related to these areas, for which we have the following generally 
defined aims: 
  
• Investigation of the equlibrium properties of CyAAZTA ligand and kinetic, 
relaxation, and structural characterization of its Gd(CyAAZTA) complex as a 
potential MRI contrast agent formed with a ligan possessing seven functional 
groups. 
• Study of the equilibrium, kinetic and strucutal properties of the Ga(CyAAZTA) 
complex as a potential PET contrast agent candidate 
• Study of the effect of free Ca2+ and Mg2+ ions on the dissociation rates of Gd3+ 
based open-chain MRI contrast agents used in clinical practice. 
• Investigation of the interactions between the open-chain Gd(DTPA-BMA) 
(Omniscan), the macrocyclic Gd(HP-DO3A) (ProHance) contrast agents and 
bone tissues. 
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Figure 1. Structure of the studied ligands 
II. EXPERIMENTAL METHODS 
  
In this work we have studied the equilibrium behaviours of the rigid 
CyAAZTA ligand, the kinetic and structural properties of the Gd (CyAAZTA) 
and Ga(CyAAZTA) complexes, as well as the relaxation properties of 
Gd(CyAAZTA). Our work included examining of the effects of the free Ca2+ and 
Mg2+ ions on the rates of metal exchange reaction some clinically used MRI Gd3+-
based contrast agents was also investigated. In addition, we explored the nature 
of interaction between the open chain Gd(DTPA-BMA) (Omniscan), the 
macrocyclic Gd(HP-DO3A) (ProHance) complexes and bone tissues. 
The  investigated new CyAAZTA ligand was synthetised by our cooperating 
partners in Italy. The equilibrium studies were performed by pH-potentiometry, 
UV-visible spectrophotometry and multinuclear NMR spectroscopy. The 
protonation constants of the ligands and the stability and protonation constants of 
the complexes formed with metal ions (Mg2+, Ca2+, Sr3+, Cu2+, Zn2+, Cd2+, Pb2+, 
Ga3+ and Ln3+) were calculated from the results of the direct pH-potentiometric 
titrations. In some cases, equilibrium data were obtained by UV-visible (Cu2+), 
1H- and 71Ga-NMR spectroscopic (Ga3+) and 1H-NMR relaxometric (Gd3+) 
studies. The kinetic inertness of the Gd(CyAAZTA) and Ga(CyAAZTA) 
complexes was characterized by the rate of the exchange reactions occuring with 
Cu2+ ion or human transferrin (sTf) studied by UV-visible spectrophotometry. 
Those physico-chemical parameters characterizing the Gd(CyAAZTA) complex, 
which determine the effect on the relaxation rate of the solvent protons, were 
calculated from the results of 1H-NMR and 17O-NMR spectroscopy studies. The 
interaction between  the Gd(CyAAZTA)(H2O)2]- complex containing two water 
molecules in the inner coordination sphere and small endogenous ligands (eg. 
citrate, phosphate, carbonate, lactate) as well as human serum albumin was 
studied by 1H NMR relaxometric technique. The structure of Cu(CyAAZTA) and 
Ga(CyAAZTA) complexes in solution was derived from the results of UV-visible 
spectrophotometry and multinuclear NMR spectroscopy. The effect of the Ca2+ 
and Mg2+ ions on the rate of exchange reactions of Gd3+ -based contrast agents 
with Cu2+ ion have been studied by UV-visible spectrophotometry, 1H- and 13C-
NMR spectroscopy and 1H NMR relaxometry. The interactions between the 
Gd(DTPA-BMA) and Gd(HP-DO3A) complexes and the bone surface were 
followed by FT-IR spectroscopy by studying the changes in the vibration band of 
the fingerprint range. 
For the pH-potentiometric titrations a Metrohm 785 DMP Titrino titration 
workstation and a Metrohm-6.0233.100 combined glass electrode were used. 
Titrations were carried out at 0.1 or 1.0 M ionic strength (KCl, KNO3), in 6 cm3 
stirred and thermostated (25°C) samples with 0.2 M KOH. The concentration was 
  
determined by titration of a KH-phthalate buffer solution of known concentration. 
To avoid the effect of CO2 during the titrations, N2 or Ar gas was bubbled through 
the samples. Two-point calibration of the pH meter was performed using 0.05 M 
KH-phthalate buffer (pH 4.005) and 0.01 M carbon-dioxide free borax buffer (N2 
atmosphere, pH = 9.180). The concentration of H+ ions from the measured pH 
values was calculated by the method proposed by Irving et al. From the titration 
data (pH-ml base) the stability and protonation constants have been calculated by 
the PSEQUAD program  
UV-visible spectrophotometric studies were performed with a Cary 1E 
spectrophotometer in a cuvette of 1 or 0.874 cm at 25 or 37 ° C using thermostated 
cuvette holder in the wavelenght ranges of 400-800 and 220-330 nm. 
The 1H, 13C and 71Ga NMR spectroscopy studies were performed with a 
Bruker DRX 400 spectrometer (9.4 T) at 400, 100 and 122 MHz using a 5 mm 
BB inverse z gradient head. The temperature was kept constant with Bruker VT-
1000 temperature control unit. The 17O NMR spectra were recorded by Bruker 
Avance III spectrometer with a 5 mm head and a standard temperature control 
unit (11.74 T) at 67.8 MHz. 
Longitudinal relaxation times (T1) were determined by Bruker MQ-20 NMR 
spectrometer at 20 MHz proton resonance frequency in 0.4 cm3 sample volume 
using the magnetization inversion technique (inversion recovery pulse sequence 
from 180° to 90°). The signal strength of T1 values was determined with a Stelar 
SmarTracer relaxometer (Proton Larmor Frequency = 0.01-10 MHz) and Stelar 
Relaxometer combined with Bruker WP80 NMR electromagnet (Proton Larmor 
Frequency = 15-80 MHz). The temperature was kept constant with Stelar VTC-
91 thermostat and measured with a calibrated copper thermocouple (± 0.1°C). 
FT-IR microspectroscopy studies were performed by Tensor 27 FT-IR 
spectrometer equipped with Hyperion 3000 FPA (focal plane array) detector. The 
spectrum of solids triturated with KBr were investigated by diffuse reflection 
infrared spectroscopy using an IFS 66v/S FT-IR spectrometer. After drying the 
liquid samples were tested with a VERTEX 80 type FT-IR spectrometer with an 
attenuated total reflection. 
 
 
 
  
III. NEW SCIENTIFIC ACHIEVEMENTS 
III.1. Compared to the analogue Ln(AAZTA) complexes the stability of 
Ln(CyAAZTA) complexes are lower due to the presence of the cyclohexyl 
group. However, the structural rigidity of complexes and, therefore the 
kinetic inertness of complexes are significantly higher, but the favorable 
relaxation properties of Gd(CyAAZTA) is unchanged. 
In order to the increase in the thermodynamic stability and kinetic inertness of 
the previously studied [Gd(AAZTA)(H2O)2]- which also has good relaxation 
properties, the cyclohexyl-AAZTA (CyAAZTA) ligand was synthetized and the 
equilibrium, kinetic, relaxation and structural properties of its complex formed 
with the Gd3+ were studied. The equilibrium studies have shown that the presence 
of cyclohexyl ring significantly reduces the flexibility of the diazepine ring, 
limiting the spatial location of the 3 amino N and 4 carboxylate-O donor atoms. 
The size of the formed rigid coordination cavity is favorable for the metal ions in 
the middle of the lanthanide series (Eu3+ and Gd3+). The structural rigidity of 
Ln(CyAAZTA)- complexes is confirmed by the 1H NMR spectra of paramagnetic 
Eu3+- and Yb(CyAAZTA)- complexes. 
The rate-determining step of the metal exchange reaction of Gd(CyAAZTA)- 
complex is the acid catalyzed dissociation of the Gd(III) complex, surprisingly 
four times slower than that of the macrocyclic Gd(DO3A). The Gd(CyAAZTA)- 
is extremely inert complex based on its dissociation half-life (t1/2 = 91.3 years) at 
physiological pH and 25°C. According to our knowledge the kinetic inertness of  
Gd(CyAAZTA)-  is the largest among the known Gd(III) complexes, formed with 
open-chain ligands, containing two  inner sphere water molecules. 
In the study of relaxation properties, we have demonstrated that two inner 
sphere water molecules in the [Gd(CyAAZTA)(H2O)2]- complex take part in 
rapid exchange processes with solvent water molecules and are not substitutable 
with endogenous ligands (lactate, citrate and phosphate) since do not occupy 
neighboring positions. The proton relaxation rate of the [Gd(CyAAZTA)(H2O)2]- 
complex in Seronorm ™ does not change in time, which clearly demonstrates the 
high stability of the Gd(III) complex under the physiological conditions. 
Due to the listed advantages, the Gd(CyAAZTA) complex is suitable for 
applying as an MRI contrast agent. 
III.2. We have found that although Ga(CyAAZTA)- is formed much more 
rapidly than the macrocyclic Ga(NOTA) and Ga(DOTA)- complexes used in 
PET, but the stability and kinetic inertness of Ga(CyAAZTA)- is significantly 
lower than those of the macrocyclic complexes. 
  
By studying the equilibrium and structural properties of the Ga(CyAAZTA)- 
complex, we demonstrated the formation of a stable mixed hydroxo 
[Ga(CyAAZTA)OH]2- complex that appears at pH>6.0. The hydroxide ion is 
directly cooerdinated to the metal ion replacing a carboxylate-O donor atom in 
the [Ga(CyAAZTA)OH]2- species. The 71Ga NMR signal of Ga(CyAAZTA)- is 
very broad at room temperature because of the the asymmetric environment of 
the Ga3+ ion which refers to the rigidity of the CyAAZTA ligand and to the 
distorted geometry of the complex. 
The kd rate constant characterizing the transmetallation reaction of 
Ga(CyAAZTA)- complex with Cu2+ ion in the presence of citrate and the kd 
values of the transchelation reactions occuring with sTf were found to be very 
similar, and we concluded that neither Cu2+ ions nor sTf are involved in the rate 
determining step of the dissociation of Ga(CyAAZTA)-. The rate-determining 
step of these exchange reactions is the spontaneous and OH-catalyzed 
dissociation of [Ga(CyAAZTA)OH]2- complex, following by the rapid reaction 
between the released Ga3+ ion and sTf or the CyAAZTA ligand with Cu2+. 
Based on the physico-chemical properties of Ga(CyAAZTA)-, the GaIII 
complex is formed more quickly, but its stability and kinetic inertness is much 
lower than those of the Ga(NOTA) and Gd(DOTA)- complexes. However, the 
rate of dissociation of Ga(CyAAZTA)- complex under physiological conditions 
(t1/ 2 = 8.5 hours) is still about 7 times lower than the decay rate of 68Ga isotope 
(68Ga, t1/2 = 67.71 min), thus 68Ga(CyAAZTA)- is a good candidate for using in 
vivo PET examinations and for the development of further 68Ga3+ based 
radiodiagnostics. 
III.3 Free Ca2+ and Mg2+ ions significantly increase the rate of dissociation of 
Gd(DTPA)2-, Gd(BOPTA)2- and Gd(EOB-DTPA)2- complexes, while they 
have no influence on the rate of dissociation of the Gd(DTPA-BMA) complex. 
In the past years, the identification of NSF disease and the accumulation of 
the gadolinium in living organisms require the detailed study of the in vivo 
equilibrium and kinetic properties of Gd3+ based MRI contrast agents. Based on 
previous studies, the Cu2+ and Zn2+ ions have no effect on the rate of dissociation 
of the Gd(III) complexes, as these endogenous metal ions do not occur in free 
form under physiological conditions. The in vivo concentration of free Ca2+ and 
Mg2+ ions are significant ([Ca2+] = 1.25 mM, [Mg2+] = 0.5 mM), but their effect 
of which on the kinetic inertness of Gd(III)-based MRI contrast agent has not 
been studied. Therefore I have studied the transmetallation reactions of the four 
  
open-chain Gd(III) complexes with Cu2+ ions in the presence of citrate, Ca2+ and 
Mg2+ ions (0.15 M NaCl, 25 and 37°C). 
Based on our kinetic studies we can say that the rate of exchange reactions 
between the charged GD(DTPA)2-, Gd(BOPTA)2- and Gd(EOB-DTPA)2- 
complexes and Cu2+ in the presence of citrate increase with growing concentration 
of  Mg2+ and Ca2+ ions, while the rates of transmetallation ractions of the 
uncharged Gd(DTPA-BMA) are not affected. Since the rate determination step of 
metal ion exchange reactions is the dissociation of Gd(III) complexes under 
physiological conditions, presumably the dissociation of the charged Gd(DTPA)2- 
derivatives take place through the formation and dissociation of a mixed binuclear 
[Gd(L)M] complex (M=Ca, Mg) in the presence of Ca2+ and Mg2+ ions . The 
binuclear Gd(L)M complexes are presumably formed by the interaction between 
a carboxylate group of the DTPA derivatives (coordinated to the Gd3+ ion) and 
the Ca2+ or Mg2+ ions, which has an effect on the interaction between the DTPA 
derivatives and the Gd3+ ion. The interaction of Gd(DTPA)2- complex with Ca2+ 
and Mg2+ ions has been proved by 1H- and 13C-NMR spectroscopy. The proton 
relaxation rates of the Gd(DTPA) derivatives measured in the presence of Ca2+ 
ion confirmed the formation of binuclear Gd(L)M complexes with Gd(DTPA)2- 
and Gd(BOPTA)2. In the binuclear Gd(L)M complex, the interaction between the 
ligand and the Gd3+ ion is weaker than in the GdL complex, which makes the 
intramolecular rearrangements in Gd(L)M complex much faster and dissociation 
more probable. Connected to our kinetic resuts it is important to mention that the 
dissociation of Gd(DTPA)2- and Gd(BOPTA)2- complexes catalysed by Ca2+ and 
Mg2+ ions is significant and can exceed the contribution of  citrate and phosphate 
ions to the dissociation rates of open-chain Gd(III) complexes under physiological 
conditions. 
III.4. Based on the FT-IR studies of the interactions between the open-chain 
Gd(DTPA-BMA) and the macrocyclic Gd(HP-DO3A) complexes and bone 
surface, it can be concluded that the presence of Gd(DTPA-BMA) causes 
irreversible changes in the bone structure, while the macrocyclic Gd(HP-
DO3A) has a weak interaction with the bones surface. 
Previous studies have shown that the in vivo dissociation of open-chain 
Gd(III) complexes (mainly Gd (DTPA-BMA)) may take place and the free Gd3+ 
ion may contribute to the emergence of NSF. Equilibrium calculations under 
physiological conditions have confirmed that the released Gd3+ ion can form 
insoluble GdPO4 precipitate with PO43- ions which can accumulate in the bones 
due to the high similarity to Ca5(PO4)3OH. During the infrared microscopy 
  
measurements, mouse bones were studied in the presence of open-chain 
Gd(DTPA-BMA) and macrocyclic Gd(HP-DO3A) complexes, which showed 
different behavior in the interactions with bones. In the presence of Gd(DTPA-
BMA) we found radical, irreversible changes in the structure of the mineral rich 
portion of the bone, which may be interpreted by the integration of GdPO4, 
formed by the released Gd3+ during the dissociation of the complex, into the bone 
surface. In the case of Gd (HP-DO3A), the accumulation of the Gd(III) complex 
in the organically rich portion of the bones is reversible, indicating that free Gd3+ 
ions are not formed, that is the macrocyclic complex does not dissociate. 
The different behavior of Gd(DTPA-BMA) and Gd(HP-DO3A) complexes 
can be interpreted their different kinetic inertness. The significantly faster 
dissociation processes of Gd(DTPA-BMA) (t1/2 = 9.3 hours) cause the release of 
substantially larger amount of Gd3+ ions, thus the GdPO4 formed can bind to the 
bone surface. In contrast to this the significantly higher kinetic inertness of 
Gd(HP-DO3A) does not allow the dissociation of the Gd3+ ions, so that, the 
interactions with bones can be formed only with intact complexes, probably 
through the hydroxypropyl side chain. 
IV. POSSIBLE APPLICATIONS OF RESULTS 
Our studies are mainly aimed to study the coordination chemistry behavior of 
the ligands and their metal complexes for basic research, but the results can be 
important in the case of their practical relevance and possible medical or 
biological applications mainly for the development of MRI and PET contrast 
agents. 
Based on the equilibrium, kinetic, relaxation and structural studies of 
Gd(CyAAZTA)-, it can be concluded that the thermodynamic stability and 
especially kinetic inertness of the complex are sufficiently high for biological and 
in vivo medical application as a safe and effective MRI contrast agents. The 
equilibrium and kinetic investigation of Ga(CyAAZTA)- complex shows that the 
presence of the cyclohexyl group reduces the stability and kinetic inertness of the 
mixed-hydroxid Ga(L)OH complex. The kinetic inertness of the Ga(CyAAZTA)- 
complex significantly increases in comparison to Ga(AAZTA)- because of the 
rigidity of the strucure of  seven-membered ring, which is promising to the 
develope a 68Ga3+ based radiopharmacon for in vivo PET studies. 
The exploration of the role of Ca2+ and Mg2+ ions in the dissociation process 
of open-chain Gd(III) complexes is very remarkable, since earlier the kinetic 
effects of the Ca2+ and Mg2+ ions were neglected. Based on our results, the extent  
of dissociation of Gd(DTPA)2- derivatives catalyzed by the free Ca2+ and Mg2+ 
  
ions in the in vivo release of Gd3+ ions is more than the contribution of the 
endogenous citrate and phosphate assisted dissociation. Our knowledge about the 
impact of Ca2+ and Mg2+ ions on the kinetic behavior of MRI contrast agents, and 
the interaction between the contrast agents and bone tissues can be a significant 
step toward the understanding of the in vivo behavior of Gd(III) complexes, 
including the exploration of the biospecification and the accumulation of the 
potentially released Gd3+ ion.  
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